Readers Chime In on Reproductive Rights, Therapy Chatbots, Medical Debt, and More
KFF Health News gives readers a chance to comment on a recent batch of stories.
Long Covid
1 - 20 of 25 Results
-
-
Long-Covid Patients Are Frustrated That Federal Research Hasn’t Found New Treatments
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.
By Sarah Boden Congress Is Out. The Presidential Campaign Is In.
Episode 308Congress is in recess until after Labor Day, and lawmakers won’t have much time when they return to get the government funded before the next fiscal year. Meanwhile, the Republican campaign for president has begun in earnest, and while repealing the Affordable Care Act is no longer the top promise, some candidates have lively ideas about what to do with federal health programs. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Phil Galewitz, who reported the latest KFF Health News-NPR “Bill of the Month,” about how a bill that should never have been sent created headaches for one patient.
-
As Pandemic Emergencies End, People Battling Long Covid Feel ‘Swept Under the Rug’
Millions of Americans suffer from long covid, which can have debilitating physical effects, including fatigue and difficulty breathing. Yet many patients feel they’re on their own.
-
KHN’s ‘What the Health?’: The Covid Response Coordinator Speaks
In this special episode of KHN’s “What the Health?” Dr. Ashish Jha, the White House coronavirus response coordinator, talks with host Julie Rovner, KHN’s chief Washington correspondent, about where we are in the pandemic and how we should transition out of the public health emergency. This episode was taped on Dec. 20.
-
The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
-
Treating Long Covid Is Rife With Guesswork
With a dearth of evidence on effective treatments for long covid, patients and doctors in 400 clinics around the country still rely on trial and error.
-
KHN’s ‘What the Health?’: The Midterm Shake-Up
Election night went better than expected for Democrats. Although they could still lose control of one or both houses of Congress, the predicted “red wave” for Republicans failed to materialize. Meanwhile, voters in both red and blue states approved ballot measures to protect abortion rights. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews Carolee Lee, the former jewelry magnate, about her efforts to boost gender equity in medical research.
-
People With Long Covid Face Barriers to Government Disability Benefits
Some people with long covid have fallen through the cracks of the government’s disability system, which was time-consuming and difficult to navigate even before the pandemic.
-
Unraveling the Interplay of Omicron, Reinfections, and Long Covid
The omicron variant has proved adept at finding hosts, often by reinfecting people who recovered from earlier bouts of covid. But whether omicron triggers long covid as often and severe as previous variants is a matter of heated study.
By Liz Szabo -
Cognitive Rehab May Help Older Adults Clear Covid-Related Brain Fog
People whose brains have been injured by concussions, traumatic accidents, strokes, or neurodegenerative conditions such as Parkinson’s disease can benefit from targeted therapy. Experts also employ therapies for long-covid patients with memory and language problems.
-
Got Long Covid? Medical Expertise Is Vital, and Seniors Should Prepare to Go Slow
Although identifying long covid in older adults can be tricky, experts say there are good strategies for getting medical advice and fighting the impact of the virus.
-
‘That’s Just Part of Aging’: Long Covid Symptoms Are Often Overlooked in Seniors
Millions of older adults are grappling with long covid, yet the impact on them has received little attention even though research suggests seniors are more likely to develop the poorly understood condition than younger or middle-aged adults.
-
When Symptoms Linger for Weeks, Is It Long Covid?
Patients with symptoms that last three to 12 weeks after an acute covid infection should adopt a “watchful waiting” approach to recovery, an expert says. Keep in contact with a primary care doctor and take it easy.
-
Covid’s ‘Silver Lining’: Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
Billions of dollars invested in mRNA vaccines and covid research could yield health care dividends for decades to come.
By Liz Szabo -
Watch: More Long-Covid Cases Seen in Kids
While covid is generally mild in children, doctors report a growing number of long-haul covid symptoms and MIS-C cases, particularly among Black and Latino children.
By Sarah Varney -
A Break From Breathlessness: How Singing Helped Me Through Long Covid
Long before covid, music therapists used singing and wind instruments to help COPD and asthma patients. These same therapies might help patients recover from covid’s lingering symptoms as well. And though it wasn’t clinical music therapy, singing with an online choir has helped me navigate long covid.
By Lydia Zuraw -
Little-Known Illnesses Turning Up in Covid Long-Haulers
A significant number of post-covid patients suffer from syndromes that few doctors understand.
By Cindy Loose -
Doctors More Likely to Prescribe Opioids to Covid ‘Long Haulers,’ Raising Addiction Fears
Chronic pain from covid can linger for months after patients appear to recover from the disease.
By Liz Szabo -
Doctors Scramble to Understand Long Covid, but Causes and Prognosis Are Elusive
Medical experts are struggling to define or explain the lingering, debilitating symptoms some covid patients experience. Part of the problem is the wide range of symptoms, but doctors say getting a better understanding will mean tracking patients and their outcomes and establishing clinical trials.
By Michelle Andrews and Lydia Zuraw